Birmingham is suing drug manufacturers and health companies, alleging they worked together to establish an “insulin pricing scheme” and inflate the cost of life-saving medicine.
Jan. 16 at 1:45 p.m. ETUnitedHealth Group's Optum Rx unit made a commitment to pass through 100% of rebates negotiated with ...
Optum, parent company of ASC chain SCA Health, has agreed to acquire infusion network FlexCare Infusion, an ambulatory infusion network based in Oklahoma City, Axios reported Jan. 15. According to the ...
4. Health services arm Optum Health's 2024 were $105.4 billion, up 10.5%. Data analytics arm Optum Insight's 2024 revenues were $18.8 billion, down 1%, and pharmaceutical services arm Optum Rx ...
UnitedHealth Group reported $14.4 billion in 2024 profits as its UnitedHealthcare health insurance and Optum provider ...
But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it ...
The company has developed technology that uses patients’ smartphones to deliver data and insights to clinicians and payers.
UnitedHealth Group (NYSE:UNH – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a ...
UnitedHealth Group has quietly but significantly scaled back its MedExpress urgent care business, with just 19 locations ...
The Oregon Health Authority has found that Eugene-based Oregon Medical Group, and two insurers, unreasonably increased ...
UnitedHealthcare's legal drug dealing arm is, according to the government, massively marking up the cost of life-saving ...
UnitedHealth Group Inc. (NYSE:UNH) is gearing up to release its fourth quarter earnings report, and investors are watching ...